These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18361072)

  • 21. A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome.
    Itoh H; Tsuji K; Sakaguchi T; Nagaoka I; Oka Y; Nakazawa Y; Yao T; Jo H; Ashihara T; Ito M; Horie M; Imoto K
    Int J Cardiol; 2007 Oct; 121(3):239-48. PubMed ID: 17445919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brugada syndrome masquerading as febrile seizures.
    Skinner JR; Chung SK; Nel CA; Shelling AN; Crawford JR; McKenzie N; Pinnock R; French JK; Rees MI
    Pediatrics; 2007 May; 119(5):e1206-11. PubMed ID: 17420262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCN5A overlap syndromes: no end to disease complexity?
    Remme CA; Wilde AA
    Europace; 2008 Nov; 10(11):1253-5. PubMed ID: 18820249
    [No Abstract]   [Full Text] [Related]  

  • 24. Provocation of silence.
    van Opstal JM; Volders PG; Crijns HJ
    Europace; 2009 Mar; 11(3):385-7. PubMed ID: 19181867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What can be done when asymptomatic patients discover they have Brugada syndrome? A case report of Brugada syndrome.
    Doetzer AD; Sotomaior VS; Bubna MH; Raskin S
    Int J Cardiol; 2011 Aug; 150(3):e96-7. PubMed ID: 20381179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?
    Meregalli PG; Wilde AA; Tan HL
    Cardiovasc Res; 2005 Aug; 67(3):367-78. PubMed ID: 15913579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated oxidative stress is associated with ventricular fibrillation episodes in patients with Brugada-type electrocardiogram without SCN5A mutation.
    Tanaka M; Nakamura K; Kusano KF; Morita H; Ohta-Ogo K; Miura D; Miura A; Nakagawa K; Tada T; Murakami M; Nishii N; Nagase S; Hata Y; Kohno K; Ouchida M; Shimizu K; Yutani C; Ohe T; Ito H
    Cardiovasc Pathol; 2011; 20(1):e37-42. PubMed ID: 20219395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation.
    Murakami M; Nakamura K; Kusano KF; Morita H; Nakagawa K; Tanaka M; Tada T; Toh N; Nishii N; Nagase S; Hata Y; Kohno K; Miura D; Ohe T; Ito H
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):389-95. PubMed ID: 20625312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome.
    Probst V; Wilde AA; Barc J; Sacher F; Babuty D; Mabo P; Mansourati J; Le Scouarnec S; Kyndt F; Le Caignec C; Guicheney P; Gouas L; Albuisson J; Meregalli PG; Le Marec H; Tan HL; Schott JJ
    Circ Cardiovasc Genet; 2009 Dec; 2(6):552-7. PubMed ID: 20031634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brugada syndrome.
    Napolitano C; Priori SG
    Orphanet J Rare Dis; 2006 Sep; 1():35. PubMed ID: 16972995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A.
    Itoh H; Shimizu M; Mabuchi H; Imoto K
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):378-83. PubMed ID: 15828879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Brugada syndrome, a rare cause of syncope].
    Auerbach H; Blank R; Jank K; Grönefeld G; Klingenheben T; Marschall C; von Mengden HJ
    Med Klin (Munich); 2005 Jun; 100(6):361-4. PubMed ID: 15968489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases.
    Six I; Hermida JS; Huang H; Gouas L; Fressart V; Benammar N; Hainque B; Denjoy I; Chahine M; Guicheney P
    Europace; 2008 Jan; 10(1):79-85. PubMed ID: 18156160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monomorphic ventricular tachycardia due to Brugada syndrome successfully treated by hydroquinidine therapy in a 3-year-old child.
    Probst V; Evain S; Gournay V; Marie A; Schott JJ; Boisseau P; LE Marec H
    J Cardiovasc Electrophysiol; 2006 Jan; 17(1):97-100. PubMed ID: 16426410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homozygous SCN5A mutation in Brugada syndrome with monomorphic ventricular tachycardia and structural heart abnormalities.
    Frigo G; Rampazzo A; Bauce B; Pilichou K; Beffagna G; Danieli GA; Nava A; Martini B
    Europace; 2007 Jun; 9(6):391-7. PubMed ID: 17442746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New familial heterozygous c 4066_4068 delTT 2 bp deletion of the SCN5A gene causing Brugada syndrome.
    Möbius-Winkler S; Dähnert I; Hindricks G; Schuler G; Adams V
    Heart Rhythm; 2011 Aug; 8(8):1224-7. PubMed ID: 21397042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands.
    Yokokawa M; Noda T; Okamura H; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S; Shimizu W
    Am J Cardiol; 2007 Aug; 100(4):649-55. PubMed ID: 17697823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A spontaneous Type 1 electrocardiogram pattern in lead V2 is an independent predictor of ventricular fibrillation in Brugada syndrome.
    Nakano Y; Shimizu W; Ogi H; Suenari K; Oda N; Makita Y; Kajihara K; Hirai Y; Sairaku A; Tokuyama T; Tonouchi Y; Ueda S; Sueda T; Chayama K; Kihara Y
    Europace; 2010 Mar; 12(3):410-6. PubMed ID: 20123697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel mutations in domain I of SCN5A cause Brugada syndrome.
    Vatta M; Dumaine R; Antzelevitch C; Brugada R; Li H; Bowles NE; Nademanee K; Brugada J; Brugada P; Towbin JA
    Mol Genet Metab; 2002 Apr; 75(4):317-24. PubMed ID: 12051963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome.
    Meregalli PG; Ruijter JM; Hofman N; Bezzina CR; Wilde AA; Tan HL
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):857-64. PubMed ID: 16764707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.